Impact BioMedical, Inc. (IBO) — Strategic Asset Allocation Index
Impact BioMedical, Inc. (IBO) has a Strategic Asset Allocation Index of 0.2% as of March 2025. Strategic assets (PP&E of $16.00K plus long-term investments of $-) total $16.00K, measured against net assets of $6.81 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See IBO net asset quality score to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Impact BioMedical, Inc. Strategic Asset Allocation Index (2021–2024)
This chart shows how Impact BioMedical, Inc.'s Strategic Asset Allocation Index has evolved across 4 annual periods from 2021 to 2024. As of March 2025, the index stands at 0.2%, representing strategic assets of $16.00K against net assets of $6.81 Million USD. For live market cap and overall valuation, see how much is Impact BioMedical, Inc. worth.
Annual Strategic Asset Allocation Index for Impact BioMedical, Inc. (2021–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Impact BioMedical, Inc. from 2021 to 2024, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See net assets of Impact BioMedical, Inc. for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 0.2% | $17.00K | $17.00K | $- | $7.24 Million | ▼ -0.8 pp |
| 2023 | 1.0% | $287.00K | $287.00K | $0.00 | $28.26 Million | ▼ -2.2 pp |
| 2022 | 3.2% | $1.06 Million | $276.00K | $782.00K | $32.67 Million | ▼ -160.4 pp |
| 2021 | 163.6% | $4.82 Million | $- | $4.82 Million | $2.94 Million | — |